The Toronto-Dominion Bank
TD
Royal Bank of Canada
RY
Canadian Imperial Bank of Commerce
CM
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
CA Stock MarketDetailed Quotes
WLLW Willow Biosciences Inc
- 0.075
- 0.0000.00%
15min DelayMarket to Open Dec 17 16:00 ET
10.82MMarket Cap-1.50P/E (TTM)
0.000High0.000Low0Volume0.000Open0.075Pre Close0.00Turnover0.14552wk High0.00%Turnover Ratio144.20MShares0.07052wk Low-0.05EPS TTM8.41MFloat Cap32500.000Historical HighLossP/E (Static)112.09MShs Float0.060Historical Low-0.1EPS LYR0.00%Amplitude--Dividend TTM75.00P/B1Lot Size--Div YieldTTM
Willow Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 61.38%-908K | 80.10%-733K | 54.20%-1.75M | 21.22%-10.92M | 74.16%-1.07M | 28.15%-2.35M | -8.10%-3.68M | -24.93%-3.82M | 23.95%-13.86M | 18.59%-4.13M |
| Net income from continuing operations | 44.15%-1.25M | 53.19%-1.69M | 50.57%-2.36M | 12.05%-13.03M | 48.51%-2.42M | 44.03%-2.23M | -14.38%-3.6M | -60.66%-4.77M | -141.27%-14.81M | 9.41%-4.71M |
| Operating gains losses | ---- | ---- | -575.00%-135K | 99.39%-23K | --0 | 96.71%-5K | 100.12%2K | 98.94%-20K | 77.52%-3.76M | 96.25%-45K |
| Depreciation and amortization | -43.73%314K | -20.50%353K | -22.12%352K | -30.80%1.83M | -22.75%377K | 20.26%558K | -45.52%444K | -48.58%452K | -17.11%2.65M | -40.63%488K |
| Asset impairment expenditure | --0 | --0 | --0 | --19K | --0 | --0 | --0 | --19K | --0 | --0 |
| Remuneration paid in stock | 118.79%65K | -32.05%106K | -70.08%158K | -71.25%420K | -59.20%82K | -194.79%-346K | -61.58%156K | 7.98%528K | -14.21%1.46M | -61.93%201K |
| Deferred tax | ---- | ---- | ---- | ---15K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | 700.00%78K | 95.00%39K | 223.08%42K | -82.24%84K | 828.57%65K | -109.92%-13K | -93.90%20K | 85.71%13K | 1,651.85%473K | -12.50%7K |
| Change In working capital | 62.10%-119K | 165.05%456K | 568.29%192K | -260.47%-207K | 1,330.43%849K | -234.04%-314K | -456.35%-701K | -109.81%-41K | 140.82%129K | -215.00%-69K |
| -Change in receivables | ---- | --135K | 110.59%18K | ---- | ---- | ---- | ---- | -2,733.33%-170K | ---- | ---- |
| -Change in inventory | ---- | --92K | -97.06%1K | ---- | ---- | ---- | ---- | 88.89%34K | ---- | ---- |
| -Change in prepaid assets | ---- | --57K | -20.25%256K | ---- | ---- | ---- | ---- | 9.93%321K | ---- | ---- |
| -Change in payables and accrued expense | ---- | --170K | 29.20%-160K | ---- | ---- | ---- | ---- | -22,700.00%-226K | ---- | ---- |
| -Change in other working capital | ---- | --2K | --77K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 61.38%-908K | 80.10%-733K | 54.20%-1.75M | 21.22%-10.92M | 74.16%-1.07M | 28.15%-2.35M | -8.10%-3.68M | -24.93%-3.82M | 23.95%-13.86M | 18.59%-4.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -678.57%-109K | 0 | -96.12%135K | 176.10%3.47M | 100.17%6K | -110.45%-14K | 99.89%-1K | 1,159.76%3.48M | -171.98%-4.55M | -1,033.11%-3.46M |
| Capital expenditure reported | 33.33%-20K | ---- | --0 | 9.24%-619K | -123.20%-58K | 83.96%-30K | ---- | ---524K | 61.38%-682K | 167.75%250K |
| Net PPE purchase and sale | --0 | --0 | --135K | -94.31%7K | -91.25%7K | --0 | ---7K | --0 | 3.36%123K | --80K |
| Net investment purchase and sale | -4.76%20K | --0 | --0 | 199.50%4M | 99.50%-20K | --21K | --1K | --4M | ---4.02M | ---4.02M |
| Net other investing changes | -2,080.00%-109K | ---- | ---- | 196.15%77K | ---- | -101.80%-5K | 101.34%5K | ---- | 196.30%26K | 265.63%234K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -678.57%-109K | --0 | -96.12%135K | 176.10%3.47M | 100.17%6K | -110.45%-14K | 99.89%-1K | 1,159.76%3.48M | -171.98%-4.55M | -1,033.11%-3.46M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 660.00%644K | 216.89%346K | 140.80%71K | 56.02%-318K | 238.34%267K | 33.53%-115K | -67.23%-296K | 3.33%-174K | -102.12%-723K | 19.25%-193K |
| Net issuance payments of debt | 52.29%-198K | 13.79%-200K | -13.79%-198K | 70.68%-212K | 413.92%609K | -139.88%-415K | -33.33%-232K | 4.40%-174K | -13.50%-723K | -18.29%-194K |
| Net common stock issuance | ---- | --0 | --270K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --1.1M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | -184.33%-253K | 953.13%546K | ---1K | ---106K | ---342K | --300K | -2,033.33%-64K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 660.00%644K | 216.89%346K | 140.80%71K | 56.02%-318K | 238.34%267K | 33.53%-115K | -67.23%-296K | 3.33%-174K | -102.12%-723K | 19.25%-193K |
| Net cash flow | ||||||||||
| Beginning cash position | -89.33%690K | -84.52%1.62M | -71.43%3.15M | -63.45%11.01M | -80.03%3.68M | -70.70%6.47M | -60.28%10.47M | -63.45%11.01M | 89.49%30.12M | -48.43%18.43M |
| Current changes in cash | 84.96%-373K | 90.28%-387K | -198.45%-1.54M | 59.38%-7.77M | 89.80%-793K | 25.10%-2.48M | 11.30%-3.98M | 85.50%-517K | -234.54%-19.14M | -38.54%-7.78M |
| Effect of exchange rate changes | 28.57%-5K | 119.05%4K | 181.82%18K | -442.31%-89K | -111.80%-42K | 97.92%-7K | -110.29%-21K | 88.83%-22K | 2,700.00%26K | 17,700.00%356K |
| Cash adjustments other than cash changes | 281.73%547K | ---547K | ---- | ---- | ---- | ---301K | --0 | ---- | ---- | ---- |
| End cash Position | -76.65%859K | -89.33%690K | -84.52%1.62M | -71.43%3.15M | -71.43%3.15M | -80.03%3.68M | -70.70%6.47M | -60.28%10.47M | -63.45%11.01M | -63.45%11.01M |
| Free cash from | 61.02%-928K | 80.14%-733K | 59.73%-1.75M | 20.66%-11.54M | 71.00%-1.12M | 31.17%-2.38M | 6.27%-3.69M | -32.73%-4.34M | 27.25%-14.54M | 28.71%-3.88M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.